2017
DOI: 10.1002/zaac.201700343
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of a Ruthenium(II) Compound based on 5‐(2‐Pyrimidyl)‐1H‐tetrazole for Photodynamic Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 10 publications
(1 citation statement)
references
References 51 publications
0
1
0
Order By: Relevance
“…[ 35 ] We found a very low IC 50 of around 23 μg mL −1 for the ND−NG−Ru (Figure 4D), which is similar to the reported IC 50 of 15 μg mL −1 of the Ru−tetrazole‐coordinated nanoparticles. [ 36 ] Live/dead staining of the cells using fluorescein diacetate/propidium iodide further demonstrated that ND−NG−Ru‐induced cell death upon irradiation could be spatially controlled (Figure 4F). Furthermore, we confirmed induced cell death using Annexin‐V, a protein that binds to phosphatidylserine, which is only present during apoptosis (Figure 4G).…”
Section: Resultsmentioning
confidence: 98%
“…[ 35 ] We found a very low IC 50 of around 23 μg mL −1 for the ND−NG−Ru (Figure 4D), which is similar to the reported IC 50 of 15 μg mL −1 of the Ru−tetrazole‐coordinated nanoparticles. [ 36 ] Live/dead staining of the cells using fluorescein diacetate/propidium iodide further demonstrated that ND−NG−Ru‐induced cell death upon irradiation could be spatially controlled (Figure 4F). Furthermore, we confirmed induced cell death using Annexin‐V, a protein that binds to phosphatidylserine, which is only present during apoptosis (Figure 4G).…”
Section: Resultsmentioning
confidence: 98%